SCHEMBL5234399

SCHEMBL5234399

CC(CC(=O)N1C(=O)OCC1c1ccccc1)c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ POLB P06746 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ IDH1 O75874 6/20 0.39
▸ NT5E P21589 1/20 0.38
▸ NAAA Q02083 1/20 0.37
▸ CACNA2D1 P54289 1/20 0.37
▸ CACNA1B Q00975 1/20 0.37
▸ CACNB1 Q02641 1/20 0.37
▸ CACNA1C Q13936 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5234391 1.00 NPC1 (0.41) NPC1LMNATP53HPGDRAB9A
SCHEMBL21447357 0.92 HPGD (0.45) NPC1LMNATP53HPGDRAB9A
SCHEMBL12634643 0.92 HPGD (0.45) NPC1LMNATP53HPGDRAB9A
SCHEMBL23699056 0.92 HPGD (0.45) NPC1LMNATP53HPGDRAB9A
SCHEMBL4684591 0.92 HPGD (0.45) NPC1LMNATP53HPGDRAB9A
SCHEMBL23699057 0.92 HPGD (0.45) NPC1LMNATP53HPGDRAB9A
SCHEMBL4684580 0.92 HPGD (0.45) NPC1LMNATP53HPGDRAB9A
SCHEMBL15872470 0.90 CACNA1B (0.46) NPC1LMNATP53HPGDRAB9A
SCHEMBL2892373 0.89 IDH1 (0.46) NPC1LMNATP53HPGDRAB9A
SCHEMBL18127777 0.89 CACNA2D1 (0.48) NPC1LMNATP53HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578414-A4 PHENYLALANINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO INC (US) 2007-10-24 — — EP disclosed
EP-1578414-A2 PHENYLALANINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES Merck & Co., Inc. (US) 2005-09-28 — — EP disclosed
WO-2004050022-A2 PHENYLALANINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK & CO., INC. (US) 2004-06-17 — — WO disclosed
Send feedback